A two-dose Pfizer/BioNTech vaccination supplies simply 33% safety in opposition to an infection by the omicron variant of the coronavirus, however 70% safety in opposition to hospitalization, in keeping with a large-scale evaluation in South Africa launched Tuesday.
The primary large-scale evaluation of vaccine effectiveness within the area the place the brand new variant was found seems to help early indications that omicron is extra simply transmissible and that the Pfizer shot isn’t as efficient in defending in opposition to an infection because it was in opposition to the delta variant.
The evaluation was based mostly on greater than 211,000 constructive COVID-19 take a look at outcomes, 41% from adults who had obtained two doses of the Pfizer vaccine. About 78,000 of those constructive COVID-19 take a look at outcomes between Nov. 15 and Dec. 7 have been attributed to omicron infections. The research was carried out by Discovery Well being, South Africa’s largest personal well being insurer, and the South African Medical Analysis Council.
The research has been carried out within the weeks since omicron was first introduced in November by scientists in South Africa and Botswana. The researchers emphasised that its findings are preliminary and never peer reviewed.
Learn extra:
Booster dose of Pfizer’s COVID-19 vaccine neutralizes Omicron variant, firm says
The info are gathered from the primary three weeks of South Africa’s omicron-driven wave and should change as time passes. South Africa is the primary nation to expertise a surge in COVID-19 pushed by the omicron variant.
South Africa has skilled fast neighborhood unfold — concentrated in its most populous province, Gauteng — dominated by the omicron variant.
The seven-day rolling common of every day new instances in South Africa has risen over the previous two weeks from 8.07 new instances per 100,000 individuals on Nov. 29 to 34.37 new instances per 100,000 individuals on Dec. 13, in keeping with Johns Hopkins College. The loss of life charge hasn’t elevated throughout that very same interval.
“Excellent genetic surveillance by the Community for Genomic Surveillance in South Africa recognized that omicron an infection accounts for over 90% of latest infections in South Africa, and has displaced the previously dominant delta variant,” Discovery Well being chief government Dr. Ryan Noach mentioned.
“The omicron-driven fourth wave has a considerably steeper trajectory of latest infections relative to prior waves. Nationwide knowledge present an exponential enhance in each new infections and take a look at positivity charges in the course of the first three weeks of this wave, indicating a extremely transmissible variant with fast neighborhood unfold of an infection,” Noach mentioned.
What does the info say about Omicron?
The consequence exhibits that vaccinated people who obtained two doses of the Pfizer vaccine have 33% safety in opposition to an infection from omicron, relative to those that have been unvaccinated within the first weeks of South Africa’s present omicron-driven wave. This represents a major drop from the 80% safety in opposition to an infection afforded in the course of the precedent days, most likely on the idea of decrease antibody susceptibility, following the intensive spike protein mutations within the omicron variant.
Encouragingly although, the consequence exhibits that these similar vaccinated people who obtained two doses of the Pfizer vaccine have 70% safety in opposition to hospital admission on this similar time interval. This safety in opposition to hospital admission is lowered from the highs of 93% in South Africa’s delta-driven variant.
The research exhibits that the safety in opposition to hospital admission is maintained throughout all ages, in individuals from 18 to 79 years outdated, with barely decrease ranges of safety for older individuals, with 67% in individuals age 60 to 69 and 60% for individuals age 70 to 79. Safety in opposition to admission can be constant throughout a spread of power diseases together with diabetes, hypertension, hypercholesterolemia, and different cardiovascular ailments.
Omicron poses a better threat of reinfection. For people who’ve beforehand had COVID-19, the danger of reinfection with omicron is considerably greater than that of earlier variants.
Danger of hospitalization from omicron is decrease. Hospital admissions amongst adults identified with COVID-19 attributed to omicron is 29% decrease in comparison with the COVID-19 wave that South Africa skilled in mid-2020, after adjusting for vaccination standing.
© 2021 World Information, a division of Corus Leisure Inc.